| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |